NCT05204225

Clinical Effectiveness of the ReHand App in Hand Rehabilitation After Stroke

Completed NA Last updated 6 April 2022

What this trial tests

NA trial testing Tablet Application in Stroke in 33 participants. Completed in 26 March 2022.

Timeline

26 January 2022

Primary endpoint
26 February 2022

26 March 2022

Quick facts

Lead sponsor	University of Seville
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	33
Start date	26 January 2022
Primary completion	26 February 2022
Estimated completion	26 March 2022
Sites	2 locations across Italy, Spain

Drugs / interventions tested

• Tablet Application
• Conventional Treatment — full drug profile →

Conditions studied

• Stroke — all drugs for Stroke →
• Mobility Limitation — all drugs for Mobility Limitation →
• Neurologic Disorder — all drugs for Neurologic Disorder →
• Motor Disorders — all drugs for Motor Disorders →

Sponsor

University of Seville

Who can join

18 and older, any sex, with Stroke or Mobility Limitation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Stroke is the third leading cause of disability worldwide, with the hand being one of the segments whose affectation generates the greatest limitation in functional ability and quality of life. Neurorehabilitation is the most effective therapy as long as it is implemented both in the early (post-hospital stages) and in an intensive approach. However, the resources of healthcare systems are not enough to address the neurorehabilitation needs of patients with hand affectation after stroke. Thus, current scientific literature advocates transferring such rehabilitation to the patient's home through therapeutic exercise programs - whose clinical and economic effectiveness has already been demonstrated - as a way of reducing the consumption of resources. In order to achieve this, telerehabilitation is suggested as one of the most viable formats. However, current telerehabilitation systems such as video games and virtual reality do not provide a fully viable solution, mainly due to the lack of scalability and penetration of the technology, and the lack of a hand specific approach, whose importance is crucial in the recovery of function and autonomy in Activities of Daily Living (ADL). Different articles and reviews confirm the potential of tablet devices to solve these issues given their scalability and the multisensory feedback provided, making possible a more productive and intensive motor training and sensory stimulation in order to optimize cortical reorganization and neuroplasticity after a stroke. Both health professionals and patients have expressed the need for a specific Tablet application for neurorehabilitation of the hand after stroke, that follows the precepts established by the evidence. However, the lack of specific applications for this approach means that existing apps are used as an adaptation. Therefore, we propose the development and preliminary validation of ReHand, the first Tablet application developed according to the needs of healthcare professionals and patients, and the precepts of the most updated scientific literature, which allows the patient to perform an active therapy adapted to its hand limitations, and the healthcare professional to monitor their patient's home performance.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.